logo

For the Inventor, By the Inventor

Basel, Switzerland

Dermavant Sciences Gmbh

USPTO Granted Patents = 21

% Expired Patents = 4.8


Trademarks = 8

Forward Citations = 37

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Sujatha Sonti (6 out of 13 patents)

silverMedal Jon Lenn (6 out of 7 patents)

bronzeMedal Joey Roger Thomas (6 out of 6 patents)

4.  Leandro Santos (6 out of 6 patents)

5.  Justin Whiteman (6 out of 6 patents)

6.  Michael Quinn Doherty (6 out of 7 patents)

7.  Mary Bedard (6 out of 6 patents)

8.  Piyush Jain (6 out of 6 patents)

9.  Susan H Smith (5 out of 5 patents)

10.  Channa K Jayawickreme (4 out of 4 patents)

11.  Cunyu Zhang (4 out of 4 patents)

12.  William Zuercher (4 out of 4 patents)

13.  Ian Paul Andrews (4 out of 4 patents)

14.  Nicholas Calandra (4 out of 4 patents)

15.  Tyler Andrew Davis (4 out of 5 patents)


21 patents:

1. 12569453 - Use of tapinarof for the treatment of atopic dermatitis (2026-03-10),
2. 12275696 - Process for preparing tapinarof (2025-04-14),
3. 12252471 - Isoquinoline compounds and their use in treating AhR imbalance (2025-03-18),
4. 11938099 - Use of tapinarof for the treatment of atopic dermatitis (2024-03-26),
5. 11827605 - Isoquinoline compounds and their use in treating AhR imbalance (2023-11-28),
6. 11622945 - Topical pharmaceutical compositions (2023-04-11),
7. 11617724 - Topical pharmaceutical compositions (2023-04-04),
8. 11612573 - Topical pharmaceutical compositions (2023-03-28),
9. 11597692 - Process for preparing tapinarof (2023-03-07),
10. 11590088 - Use of Tapinarof for the treatment of chronic plaque psoriasis (2023-02-28),
11. 11548853 - Isoquinoline compounds and their use in treating AhR imbalance (2023-01-10),
12. 11497718 - Use of tapinarof for the treatment of atopic dermatitis (2022-11-15),
13. 11458108 - Topical pharmaceutical compositions (2022-10-04),
14. 11267788 - Isoquinoline compounds and their use in treating AhR imbalance (2022-03-08),
15. 10961175 - Process for preparing tapinarof (2021-03-30),
Company Overview
Dermavant Sciences GmbH is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapies for dermatological conditions. The organization specializes in advanced research and technology aimed at addressing unmet medical needs in skin health. With a commitment to improving patient outcomes, Dermavant leverages its expertise in drug development to create effective solutions for various skin disorders, emphasizing a patient-centric approach in its therapeutic advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

21 Patents

#27 in Basel

#593 in Switzerland

#30,001 in the World

Basel, CH
Basel, Switzerland

Dermavant Sciences Gmbh

Forward Citations = 37

29 inventors:

goldMedal Sujatha Sonti (6 out of 13 patents)

silverMedal Jon Lenn (6 out of 7 patents)

bronzeMedal Joey Roger Thomas (6 out of 6 patents)

4.  Leandro Santos (6 out of 6 patents)

5.  Justin Whiteman (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dermavant Sciences Gmbh. Retrieved from https://idiyas.com/company/dermavant-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…